CompletedNCT00232414
Quetiapine for depression in young people with bipolarity
About this title
Read the official source — NCT00232414Medication studyAges 12–18United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 12 years to 18 years. Other eligibility criteria applied.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateOctober 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT00232414
- Official title
Show the full official title
A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 12 years to 18 years. Other eligibility criteria applied.
